Agencies issue update on ethylene oxide risk from commercial sterilizers

Aug 03, 2022 - 04:01 PM
fda-update-breast-implant

The Environmental Protection Agency today released a list of commercial medical device sterilizing facilities where lifetime risk from ethylene oxide emissions are highest to people who live nearby. In addition, the Food and Drug Administration released a statement highlighting how the agency is working to reduce ethylene oxide use and support innovation in medical device sterilization, while underscoring its concern about potential shortages that could result from disruptions in sterilizer operations. About half of medical devices are sterilized using ethylene oxide. The EPA will host an Aug. 10 webinar to update and hear from stakeholders as it prepares to propose an air pollution regulation next year to address ethylene oxide emissions. Register here to attend.

Related News Articles

Headline
FDA announces recall for certain IV bags
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride…
Headline
Recall issued for aspiration system by Q’Apel Medical
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports…
Headline
FDA issues alerts on certain catheters produced by BD, Conavi
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue…
Headline
FDA recalls Medtronic Aortic Root Cannulas 
The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of unexpected loose material in the male luer…
Blog
Can Collaborative Efforts to Improve Device Design Improve Safety?
Public
During World War II, the U.S. Army Air Corps depended on its B-17 bombers to inflict incredible damage against the Axis powers in Europe. These “Flying…
Headline
Recall issued for Becton, Dickinson and Company infusion pump adapters
The Food and Drug Administration has identified a Class I recall of Becton, Dickinson and Company BD Alaris Systems Manager and BD Care Coordination Engine…